NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









VisiCELL Medical

VisiCELL Medical

Private
San Diego, CaliforniaHealthcare & Life Scienceshttps://www.visicellmedical.com/

Last Round

Grant

Nov 19, 2025

Total Funding Raised

$1.29M

Company Overview

VisiCELL Medical is a biotechnology company that develops non-invasive, imaging-based solutions for the cell therapy industry.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Medical Imaging, Clinical Trials, Biotech Equipment

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting

AI Layer

Application

Keywords

cell trackingcell therapyMRI imagingin vivo imagingcell labelingnon-invasive imagingbiodistributionbiotech equipmentclinical trialscell therapy monitoringmolecular imagingnanomaterialsCAR-T trackinglive cell imagingbiotech R&D

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

VisiCELL Medical Comparables

Compare VisiCELL Medical with similar companies based on industry and business-model similarity.

VisiCELL Medical comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
CellTrack Corp
79%
BioPhysics Assay Laboratory
77%
CellSight Technologies
76%

VisiCELL Medical Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantNov 19, 2025
AcceleratorJun 10, 2025
GrantMar 1, 2022
Convertible DebtFeb 23, 2021
AngelMar 29, 2020
Grant
Nov 30, 2018

Key People

Founding team and executive leadership

Mya S. Thu

Co-Founder And CEO

Founding Team

Johnny Akers

Chief Operating Officer

Executive Team

VisiCELL Medical Investors

Notable investors and investment history

VisiCELL Medical investors
InvestorRounds
StartXConvertible Debt
Biomedical Advanced Research and Development AuthorityAccelerator
BioTools InnovatorGrant, Accelerator
Harmonix FundConvertible Debt
TCA Venture GroupConvertible Debt
Life Science AngelsConvertible Debt
San Diego Angel ConferenceAngel

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 1, 2022

    $276K grant from the National Science Foundation.

VisiCELL Medical Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

VisiCELL Medical Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about VisiCELL Medical's valuation, stock price, and market status.

Firmographic Details

HeadquartersSan Diego, California
Employee Range11
Year Founded2012
Last FundingNov 19, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.